Clinical Trial Update: REV 002 Observational Study of the ReVENT Sleep Apnea System: Minimally Invasive Treatment for Obstructive Sleep Apnea

View source ↗

Summary

The REV 002 observational study evaluating the ReVENT Sleep Apnea System for obstructive sleep apnea has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• ReVENT Sleep Apnea System

Snippet

Sponsor: Revent Medical International B.V. | Conditions: Obstructive Sleep Apnea | Status: TERMINATED